Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors

摘要

Disclosed are ten compounds of general formula (I), whose specific formulas are disclosed in the specification. Also described are more compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are useful as Trk kinase inhibitors, and for treating diseases such as cancer.